We last looked at Pfizer (PFE) back on March 8 and wrote that "PFE may continue to hold around $34 and that's okay but the quantitative downgrade to hold and a Point and Figure target of $30 tells us to be careful as we could see a retest of the June low in the weeks ahead. It may not happen but luck favors the prepared."
More from Investing
The e-commerce giant is spending heavily on bulk buying, a risky strategy on the fiercest battlefield in China's Internet space.
Wait for more signs of accumulation (buying) before probing the long side.
The market seems to rejoice from the latest mask utterance out of the CDC, but the action at the Nasdaq should give traders pause.